Recomienda este artículo a tus amigos:
Modern Strategy for Preclinical Pharmaceutical R&D: Towards the Virtual Research Company Cavalla, David (Napp Research Centre, Cambridge, UK)
Precio
$ 283,99
sin IVA
Pedido desde almacén remoto
Entrega prevista 19 de jun. - 8 de jul.
Nuestros clientes opinan:
Añadir a tu lista de deseos de iMusic
Modern Strategy for Preclinical Pharmaceutical R&D: Towards the Virtual Research Company
Cavalla, David (Napp Research Centre, Cambridge, UK)
The emphasis on cost-effectiveness within the pharmaceutical industry has caused it to outsource some development work. This text addresses the advantages and disadvantages of collaborations between industrial research and development divisions and contract research organizations and universities.
228 pages, Ill.
| Medios de comunicación | Libros Hardcover Book (Libro con lomo y cubierta duros) |
| Publicado | 7 de octubre de 1997 |
| ISBN13 | 9780471971177 |
| Editores | John Wiley & Sons Inc |
| Páginas | 228 |
| Dimensiones | 163 × 242 × 18 mm · 498 g |
| Lengua | Inglés |
